Viewing Study NCT00951457


Ignite Creation Date: 2025-12-24 @ 6:31 PM
Ignite Modification Date: 2026-03-06 @ 12:59 PM
Study NCT ID: NCT00951457
Status: COMPLETED
Last Update Posted: 2022-03-03
First Post: 2009-08-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bendamustine Combined With Alemtuzumab in Pretreated Chronic Lymphocytic Leukemia (CLL)
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module